Showing results (21-30 of 60) with videos related to

Sort By:
Pageof 6
Clinical Lymphoma, Myeloma & Leukemia|August 20, 2021
IVAC With or Without Rituximab for Relapsed or Refractory B-Cell Non-Hodgkin Lymphomas: Real-World Experience in the Modern EraMichael J Buege, Phuong H Dao, Esther Drill, et al.
Cancer|September 16, 2006
Quality-of-life and health benefits of early treatment of mild anemia: a randomized trial of epoetin alfa in patients receiving chemotherapy for hematologic malignanciesDavid J Straus, Marcia A Testa, Brenda J Sarokhan, et al.
Blood|August 19, 2004
Results of a prospective randomized clinical trial of doxorubicin, bleomycin, vinblastine, and dacarbazine (ABVD) followed by radiation therapy (RT) versus ABVD alone for stages I, II, and IIIA nonbulky Hodgkin diseaseDavid J Straus, Carol S Portlock, Jing Qin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 27, 2007
Dose-reduced busulfan, cyclophosphamide, and autologous stem cell transplantation for human immunodeficiency virus-associated lymphoma: AIDS Malignancy Consortium study 020Thomas R Spitzer, Richard F Ambinder, Jeannette Y Lee, et al.
Cancer|September 16, 2003
Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphomaEunice S Wang, David J Straus, Julie Teruya-Feldstein, et al.
British Journal of Haematology|August 24, 2005
Primary mediastinal large B-cell lymphoma: optimal therapy and prognostic factor analysis in 141 consecutive patients treated at Memorial Sloan Kettering from 1980 to 1999Paul A Hamlin, Carol S Portlock, David J Straus, et al.
Blood|April 5, 2003
Age-adjusted International Prognostic Index predicts autologous stem cell transplantation outcome for patients with relapsed or primary refractory diffuse large B-cell lymphomaPaul A Hamlin, Andrew D Zelenetz, Tarun Kewalramani, et al.
Leukemia & Lymphoma|March 17, 2012
Interim [(18)F]fluorodeoxyglucose positron emission tomography imaging in stage I-II non-bulky Hodgkin lymphoma: would using combined positron emission tomography and computed tomography criteria better predict response than each test alone?Lale Kostakoglu, Heiko Schöder, Jeffrey L Johnson, et al.
British Journal of Haematology|October 16, 2014
Phase I/II trial of vorinostat with rituximab, cyclophosphamide, etoposide and prednisone as palliative treatment for elderly patients with relapsed or refractory diffuse large B-cell lymphoma not eligible for autologous stem cell transplantationDavid J Straus, Paul A Hamlin, Matthew J Matasar, et al.
Blood Advances|March 31, 2021
Involved-site radiotherapy for Helicobacter pylori-independent gastric MALT lymphoma: 26 years of experience with 178 patientsJoachim Yahalom, Amy J Xu, Ariela Noy, et al.
Pageof 6